Global Antibody Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Antibody Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

According to APO Research, The global Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Antibody include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Antibody sales, projected growth trends, production technology, application and end-user industry.

Antibody segment by Company

Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Antibody segment by Type

IgM
IgG
IgA
Other
Antibody segment by Application

Therapeutic
Research
Diagnostic
Antibody segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Antibody market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Antibody significant trends, drivers, influence factors in global and regions.
6. To analyze Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibody industry.
Chapter 3: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Antibody in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Antibody Sales Value (2019-2030)
1.2.2 Global Antibody Sales Volume (2019-2030)
1.2.3 Global Antibody Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Antibody Market Dynamics
2.1 Antibody Industry Trends
2.2 Antibody Industry Drivers
2.3 Antibody Industry Opportunities and Challenges
2.4 Antibody Industry Restraints
3 Antibody Market by Company
3.1 Global Antibody Company Revenue Ranking in 2023
3.2 Global Antibody Revenue by Company (2019-2024)
3.3 Global Antibody Sales Volume by Company (2019-2024)
3.4 Global Antibody Average Price by Company (2019-2024)
3.5 Global Antibody Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Antibody Company Manufacturing Base & Headquarters
3.7 Global Antibody Company, Product Type & Application
3.8 Global Antibody Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Antibody Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Antibody Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Antibody Market by Type
4.1 Antibody Type Introduction
4.1.1 IgM
4.1.2 IgG
4.1.3 IgA
4.1.4 Other
4.2 Global Antibody Sales Volume by Type
4.2.1 Global Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Sales Volume by Type (2019-2030)
4.2.3 Global Antibody Sales Volume Share by Type (2019-2030)
4.3 Global Antibody Sales Value by Type
4.3.1 Global Antibody Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Antibody Sales Value by Type (2019-2030)
4.3.3 Global Antibody Sales Value Share by Type (2019-2030)
5 Antibody Market by Application
5.1 Antibody Application Introduction
5.1.1 Therapeutic
5.1.2 Research
5.1.3 Diagnostic
5.2 Global Antibody Sales Volume by Application
5.2.1 Global Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Antibody Sales Volume by Application (2019-2030)
5.2.3 Global Antibody Sales Volume Share by Application (2019-2030)
5.3 Global Antibody Sales Value by Application
5.3.1 Global Antibody Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Antibody Sales Value by Application (2019-2030)
5.3.3 Global Antibody Sales Value Share by Application (2019-2030)
6 Antibody Market by Region
6.1 Global Antibody Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Antibody Sales by Region (2019-2030)
6.2.1 Global Antibody Sales by Region: 2019-2024
6.2.2 Global Antibody Sales by Region (2025-2030)
6.3 Global Antibody Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Antibody Sales Value by Region (2019-2030)
6.4.1 Global Antibody Sales Value by Region: 2019-2024
6.4.2 Global Antibody Sales Value by Region (2025-2030)
6.5 Global Antibody Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Antibody Sales Value (2019-2030)
6.6.2 North America Antibody Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Antibody Sales Value (2019-2030)
6.7.2 Europe Antibody Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Antibody Sales Value (2019-2030)
6.8.2 Asia-Pacific Antibody Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Antibody Sales Value (2019-2030)
6.9.2 Latin America Antibody Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Antibody Sales Value (2019-2030)
6.10.2 Middle East & Africa Antibody Sales Value Share by Country, 2023 VS 2030
7 Antibody Market by Country
7.1 Global Antibody Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Antibody Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Antibody Sales by Country (2019-2030)
7.3.1 Global Antibody Sales by Country (2019-2024)
7.3.2 Global Antibody Sales by Country (2025-2030)
7.4 Global Antibody Sales Value by Country (2019-2030)
7.4.1 Global Antibody Sales Value by Country (2019-2024)
7.4.2 Global Antibody Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.5.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.6.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.7.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.8.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.9.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.10.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.11.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.12.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.13.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.14.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.15.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.16.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.17.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.18.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.19.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.20.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.21.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.22.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Antibody Sales Value Growth Rate (2019-2030)
7.23.2 Global Antibody Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Antibody Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Antibody Sales, Value and Gross Margin (2019-2024)
8.1.4 Roche Antibody Product Portfolio
8.1.5 Roche Recent Developments
8.2 Johnson and Johnson
8.2.1 Johnson and Johnson Comapny Information
8.2.2 Johnson and Johnson Business Overview
8.2.3 Johnson and Johnson Antibody Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson and Johnson Antibody Product Portfolio
8.2.5 Johnson and Johnson Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Antibody Sales, Value and Gross Margin (2019-2024)
8.3.4 Merck Antibody Product Portfolio
8.3.5 Merck Recent Developments
8.4 Novartis
8.4.1 Novartis Comapny Information
8.4.2 Novartis Business Overview
8.4.3 Novartis Antibody Sales, Value and Gross Margin (2019-2024)
8.4.4 Novartis Antibody Product Portfolio
8.4.5 Novartis Recent Developments
8.5 AbbVie
8.5.1 AbbVie Comapny Information
8.5.2 AbbVie Business Overview
8.5.3 AbbVie Antibody Sales, Value and Gross Margin (2019-2024)
8.5.4 AbbVie Antibody Product Portfolio
8.5.5 AbbVie Recent Developments
8.6 Amgen
8.6.1 Amgen Comapny Information
8.6.2 Amgen Business Overview
8.6.3 Amgen Antibody Sales, Value and Gross Margin (2019-2024)
8.6.4 Amgen Antibody Product Portfolio
8.6.5 Amgen Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Antibody Sales, Value and Gross Margin (2019-2024)
8.7.4 Pfizer Antibody Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Antibody Sales, Value and Gross Margin (2019-2024)
8.8.4 Bayer Antibody Product Portfolio
8.8.5 Bayer Recent Developments
8.9 Lilly
8.9.1 Lilly Comapny Information
8.9.2 Lilly Business Overview
8.9.3 Lilly Antibody Sales, Value and Gross Margin (2019-2024)
8.9.4 Lilly Antibody Product Portfolio
8.9.5 Lilly Recent Developments
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Comapny Information
8.10.2 Bristol-Myers Squibb Business Overview
8.10.3 Bristol-Myers Squibb Antibody Sales, Value and Gross Margin (2019-2024)
8.10.4 Bristol-Myers Squibb Antibody Product Portfolio
8.10.5 Bristol-Myers Squibb Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Antibody Sales, Value and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Antibody Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
8.12 Biogen
8.12.1 Biogen Comapny Information
8.12.2 Biogen Business Overview
8.12.3 Biogen Antibody Sales, Value and Gross Margin (2019-2024)
8.12.4 Biogen Antibody Product Portfolio
8.12.5 Biogen Recent Developments
8.13 AstraZeneca
8.13.1 AstraZeneca Comapny Information
8.13.2 AstraZeneca Business Overview
8.13.3 AstraZeneca Antibody Sales, Value and Gross Margin (2019-2024)
8.13.4 AstraZeneca Antibody Product Portfolio
8.13.5 AstraZeneca Recent Developments
8.14 Sanofi
8.14.1 Sanofi Comapny Information
8.14.2 Sanofi Business Overview
8.14.3 Sanofi Antibody Sales, Value and Gross Margin (2019-2024)
8.14.4 Sanofi Antibody Product Portfolio
8.14.5 Sanofi Recent Developments
8.15 Alexion Pharmaceuticals
8.15.1 Alexion Pharmaceuticals Comapny Information
8.15.2 Alexion Pharmaceuticals Business Overview
8.15.3 Alexion Pharmaceuticals Antibody Sales, Value and Gross Margin (2019-2024)
8.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
8.15.5 Alexion Pharmaceuticals Recent Developments
8.16 Seattle Genetics
8.16.1 Seattle Genetics Comapny Information
8.16.2 Seattle Genetics Business Overview
8.16.3 Seattle Genetics Antibody Sales, Value and Gross Margin (2019-2024)
8.16.4 Seattle Genetics Antibody Product Portfolio
8.16.5 Seattle Genetics Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Antibody Value Chain Analysis
9.1.1 Antibody Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Antibody Sales Mode & Process
9.2 Antibody Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Antibody Distributors
9.2.3 Antibody Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings